PMID- 34578846 OWN - NLM STAT- MEDLINE DCOM- 20211122 LR - 20211122 IS - 2072-6643 (Electronic) IS - 2072-6643 (Linking) VI - 13 IP - 9 DP - 2021 Aug 26 TI - Concurrent Chemoradiotherapy Induces Body Composition Changes in Locally Advanced Head and Neck Squamous Cell Carcinoma: Comparison between Oral Cavity and Non-Oral Cavity Cancer. LID - 10.3390/nu13092969 [doi] LID - 2969 AB - Few prospective cohort trials have evaluated the difference in treatment-interval total body composition (TBC) changes assessed by dual-energy X-ray absorptiometry (DXA) between two patient subgroups with locally advanced head and neck squamous cell carcinoma (LAHNSCC) receiving concurrent chemoradiotherapy (CCRT): oral cavity cancer with adjuvant CCRT (OCC) and non-oral cavity with primary CCRT (NOCC). This study prospectively recruited patients with LAHNSCC. Clinicopathological variables, blood nutritional/inflammatory markers, CCRT-related factors, and TBC data assessed by DXA before and after treatment were collected. Multivariate linear regression analysis identified the factors associated with treatment-interval changes in body composition parameters, including lean body mass (LBM), total fat mass (TFM), and bone mineral content (BMC). A total of 127 patients (OCC (n = 69) and NOCC (n = 58)) were eligible. Body composition parameters were progressively lost during CCRT in both subgroups. Extremities lost more muscle mass than the trunk for LBM, whereas the trunk lost more fat mass than the extremities for TFM. BMC loss preferentially occurred in the trunk region. Different factors were independently correlated with the interval changes of each body composition parameter for both OCC and NOCC subgroups, particularly mean daily calorie intake for LBM and TFM loss, and total lymphocyte count for BMC loss. In conclusion, treatment-interval TBC changes and related contributing factors differ between the OCC and NOCC subgroups. FAU - Lin, Yu-Ching AU - Lin YC AUID- ORCID: 0000-0002-2318-8507 AD - Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital, College of Medicine, Keelung & Chang Gung University, Taoyuan 333007, Taiwan. AD - Osteoporosis Prevention and Treatment Center, Chang Gung Memorial Hospital, Keelung 20401, Taiwan. FAU - Ling, Hang Huong AU - Ling HH AUID- ORCID: 0000-0003-4662-1235 AD - Division of Hemato-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, College of Medicine, Keelung & Chang Gung University, Taoyuan 333007, Taiwan. FAU - Chang, Pei-Hung AU - Chang PH AD - Division of Hemato-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, College of Medicine, Keelung & Chang Gung University, Taoyuan 333007, Taiwan. FAU - Pan, Yi-Ping AU - Pan YP AD - Department of Nutrition, Chang Gung Memorial Hospital, Keelung 20401, Taiwan. FAU - Wang, Cheng-Hsu AU - Wang CH AD - Division of Hemato-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, College of Medicine, Keelung & Chang Gung University, Taoyuan 333007, Taiwan. FAU - Chou, Wen-Chi AU - Chou WC AD - Division of Hemato-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, College of Medicine, Linkou & Chang Gung University, Taoyuan 333007, Taiwan. FAU - Chen, Fang-Ping AU - Chen FP AUID- ORCID: 0000-0001-5228-5755 AD - Osteoporosis Prevention and Treatment Center, Chang Gung Memorial Hospital, Keelung 20401, Taiwan. AD - Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Keelung 20401, Taiwan. AD - Healthy Aging Research Center, College of Medicine, Chang Gung University, Taoyuan 333007, Taiwan. FAU - Yeh, Kun-Yun AU - Yeh KY AUID- ORCID: 0000-0001-5572-7897 AD - Division of Hemato-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, College of Medicine, Keelung & Chang Gung University, Taoyuan 333007, Taiwan. LA - eng GR - MOST 108-2314-B-182A-018-MY3/Ministry of Science and Technology, Taiwan/ GR - CMRPG2E0101-CMRPG2E0103, CMRPG2J0171, CMRPG2G0611, and CORPG2F0011-13/Chang Gung Memorial Hospital/ PT - Comparative Study PT - Journal Article DEP - 20210826 PL - Switzerland TA - Nutrients JT - Nutrients JID - 101521595 SB - IM MH - Body Composition/*physiology MH - Bone Density/physiology MH - Chemoradiotherapy/*methods MH - Cohort Studies MH - Female MH - Head and Neck Neoplasms/physiopathology/*therapy MH - Humans MH - Male MH - Middle Aged MH - Mouth Neoplasms/physiopathology/therapy MH - Prospective Studies MH - Squamous Cell Carcinoma of Head and Neck/physiopathology/*therapy PMC - PMC8472371 OTO - NOTNLM OT - DXA OT - bone mineral content OT - concurrent chemoradiotherapy OT - head and neck cancer OT - lean body mass OT - total fat mass COIS- The authors declare no conflict of interest. EDAT- 2021/09/29 06:00 MHDA- 2021/11/23 06:00 PMCR- 2021/08/26 CRDT- 2021/09/28 01:27 PHST- 2021/08/01 00:00 [received] PHST- 2021/08/22 00:00 [revised] PHST- 2021/08/24 00:00 [accepted] PHST- 2021/09/28 01:27 [entrez] PHST- 2021/09/29 06:00 [pubmed] PHST- 2021/11/23 06:00 [medline] PHST- 2021/08/26 00:00 [pmc-release] AID - nu13092969 [pii] AID - nutrients-13-02969 [pii] AID - 10.3390/nu13092969 [doi] PST - epublish SO - Nutrients. 2021 Aug 26;13(9):2969. doi: 10.3390/nu13092969.